Alnylam Pharmaceuticals, Inc.
DE ˙ XTRA ˙ US02043Q1076
251,80 € ↑6,70 (2,73%)
2026-06-03
DEL PRIS
SecurityDE:DUL / Alnylam Pharmaceuticals, Inc.
InstitutionBarclays Plc
Latest Disclosed Ownership222,561 shares
Latest Disclosed Value $ 88,501,381
Barclays Plc ownership in DUL / Alnylam Pharmaceuticals, Inc.

On February 13, 2026 - Barclays Plc filed a 13F-HR form disclosing ownership of 222,561 shares of Alnylam Pharmaceuticals, Inc. (DE:DUL) valued at $75,203,362 USD as of December 31, 2025. The entity filed a previous 13F-HR/A on March 31, 2026 disclosing 94,408 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 135.74% during the quarter. The current value of the position is $56,040,860 USD.

Barclays Plc has a history of taking positions in derivatives of the underlying security (DUL) in the form of stock options. The firm currently holds call options representing 63,000 of underlying shares valued at $25,051,950 USD and put options representing 10,000 of underlying shares valued at $3,976,500 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:DUL / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 222,561 128,153 135.74 88,501 105.58 0.0212
2026-03-31 2025-09-30 13F/A-3 ALNYLAM PHARMACEUTICALS COM 02043Q107 94,408 350 0.37 43,050 40.36 0.0093
2026-03-19 2025-09-30 13F/A-2 ALNYLAM PHARMACEUTICALS COM 02043Q107 105,185 11,127 28,929 0.0077
2025-11-12 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 94,408 350 43,050 0.0093
2026-02-27 2025-06-30 13F/A-2 ALNYLAM PHARMACEUTICALS COM 02043Q107 94,058 -1,661 -1.74 30,671 18.67 0.0070
2025-08-14 2025-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 94,058 -1,661 31 0.0070
2025-08-13 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 94,058 -1,661 31 0.0023
2026-03-17 2025-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 95,719 -8,128 -7.83 25,846 5.77 0.0073
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 95,719 -8,128 26 0.0073
2026-03-19 2024-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 103,847 -1,338 -1.27 24,436 -15.53 0.0068
2025-02-13 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 103,847 -1,338 24 0.0068
2026-03-31 2024-09-30 13F/A-2 ALNYLAM PHARMACEUTICALS COM 02043Q107 105,185 -26,080 -19.87 28,929 -9.30 0.0077
2024-11-19 2024-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 105,185 -26,080 29 0.0077
2024-11-15 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 105,185 -26,080 29 0.0023
2026-03-23 2024-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 131,265 -62,707 -32.33 31,897 10.03 0.0098
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 131,265 -62,707 32 0.0098
2026-03-24 2024-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 193,972 51,972 36.60 28,989 6.66 0.0101
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 193,972 51,972 29 0.0101
2026-03-25 2023-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 142,000 -20,195 -12.45 27,180 -5.38 0.0100
2024-02-15 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 142,000 -20,195 27 0.0100
2026-03-26 2023-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 162,195 -47,950 -22.82 28,725 -28.04 0.0179
2023-11-07 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 162,195 -47,950 29 0.0179
2026-03-30 2023-06-30 13F/A-2 ALNYLAM PHARMACEUTICALS COM 02043Q107 210,145 68,550 48.41 39,915 40.72 0.0253
2023-09-20 2023-06-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 210,145 68,550 40 0.0253
2023-08-03 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 210,145 68,550 40 0.0252
2026-03-30 2023-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 141,595 -20,539 -12.67 28,364 -26.39 0.0130
2023-05-04 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 141,595 -20,539 28 0.0130
2026-03-30 2022-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 162,134 20,780 14.70 38,531 36.19 0.0173
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 162,134 20,780 39 0.0173
2022-11-03 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 141,354 15,233 12.08 28,292 53.80 0.0309
2022-08-12 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 126,121 46,523 58.45 18,395 41.53 0.0113
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 79,598 -2,367 -2.89 12,997 -6.49 0.0102
2022-02-23 2021-12-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 81,965 -15,510 -15.91 13,899 -24.47 0.0052
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 81,965 -15,510 13,899 0.0052
2021-11-09 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 97,475 -5,551 -5.39 18,403 5.37 0.0083
2021-08-13 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 103,026 25,161 32.31 17,465 58.84 0.0083
2021-05-13 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 77,865 14,890 23.64 10,995 34.33 0.0059
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 62,975 -31,520 -33.36 8,185 -40.51 0.0043
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 94,495 -21,693 -18.67 13,759 -20.04 0.0082
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 116,188 13,473 13.12 17,208 53.89 0.0133
2020-05-13 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 102,715 41,557 67.95 11,182 58.75 0.0088
2020-02-10 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 61,158 -39,729 -39.38 7,044 -13.19 0.0039
2019-11-15 2019-09-30 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 100,887 34,994 53.11 8,114 69.75 0.0051
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 100,887 34,994 8,114 1,875.9660
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 65,893 15,770 31.46 4,780 2.07 0.0029
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 50,123 -23,443 -31.87 4,683 -12.70 0.0032
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 73,566 3,892 5.59 5,364 -12.04 0.0041
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 69,674 19,562 39.04 6,098 23.54 0.0042
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 50,112 33,094 194.46 4,936 143.63 0.0042
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 17,018 -68,526 -80.11 2,026 -81.36 0.0015
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 85,544 74,097 647.30 10,869 708.71 0.0089
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 11,447 -42,875 -78.93 1,344 -68.98 0.0014
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 54,322 3,689 7.29 4,332 66.94 0.0046
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 50,633 -539 -1.05 2,595 35.37 0.0028
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 51,172 33,285 186.08 1,917 58.04 0.0021
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 17,887 8,385 88.24 1,213 130.17 0.0013
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9,502 -18,734 -66.35 527 -69.92 0.0007
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 28,236 15,269 117.75 1,752 43.84 0.0027
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 12,967 -26,166 -66.86 1,218 -61.10 0.0015
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 39,133 26,649 213.47 3,131 110.70 0.0038
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 12,484 3,617 40.79 1,486 61.17 0.0017
2015-05-19 2015-03-31 13F/A-1 ALNYLAM PHARMACEUTICALS COM 02043Q107 8,867 8,339 1,579.36 922 1,707.84 0.0011
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 8,867 922
2015-02-13 2014-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 528 -32,831 -98.42 51 -98.04 0.0000
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 33,359 -28,462 -46.04 2,602 -33.18 0.0025
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 61,821 51,955 526.61 3,894 489.11 0.0041
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 9,866 -18,099 -64.72 661 -63.03 0.0007
2014-02-13 2013-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 27,965 19,987 250.53 1,788 250.59 0.0018
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,978 -35,234 -81.54 510 -61.94 0.0006
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 43,212 43,212 1,340 0.0017
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 63,000 229.84 25,052 376.89 n/a n/a n/a
2026-03-19 2025-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Call 19,100 5,253 n/a n/a n/a
2026-03-17 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 0 0 n/a n/a n/a
2026-03-19 2024-12-31 13F/A ALNYLAM PHARMACEUTICALS OPT Call 7,300 -61.78 1,718 -67.31 n/a n/a n/a
2025-02-13 2024-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 7,300 2 n/a n/a n/a
2024-11-19 2024-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Call 19,100 5 n/a n/a n/a
2026-03-31 2024-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Call 19,100 -75.97 5,253 -72.81 n/a n/a n/a
2024-11-15 2024-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 19,100 5 n/a n/a n/a
2026-03-23 2024-06-30 13F/A ALNYLAM PHARMACEUTICALS OPT Call 79,500 177.00 19,318 350.41 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 79,500 19 n/a n/a n/a
2026-03-24 2024-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Call 28,700 -35.36 4,289 -49.53 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 28,700 4 n/a n/a n/a
2026-03-25 2023-12-31 13F/A ALNYLAM PHARMACEUTICALS OPT Call 44,400 8,499 n/a n/a n/a
2024-02-15 2023-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 44,400 8 n/a n/a n/a
2023-09-21 2023-06-30 13F/A ALNYLAM PHARMACEUTICALS OPT Call 0 0 n/a n/a n/a
2026-03-30 2023-06-30 13F/A ALNYLAM PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-03 2023-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 0 0 n/a n/a n/a
2026-03-30 2023-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Call 45,400 -38.23 9,095 -47.94 n/a n/a n/a
2023-05-04 2023-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 45,400 9 n/a n/a n/a
2026-03-30 2022-12-31 13F/A ALNYLAM PHARMACEUTICALS OPT Call 73,500 17,467 n/a n/a n/a
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 73,500 17 n/a n/a n/a
2021-11-09 2021-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-13 2021-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 30,000 5,086 n/a n/a n/a
2021-05-13 2021-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 600 0.00 78 -10.34 n/a n/a n/a
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 600 0.00 87 -2.25 n/a n/a n/a
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 600 -98.59 89 -98.09 n/a n/a n/a
2020-05-13 2020-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 42,700 -40.36 4,648 -43.63 n/a n/a n/a
2020-02-10 2019-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 71,600 244.23 8,246 392.89 n/a n/a n/a
2019-11-15 2019-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Call 20,800 50.72 1,673 67.13 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 20,800 1,673 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 13,800 -10.39 1,001 -30.44 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 15,400 -58.60 1,439 -46.94 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 37,200 -28.05 2,712 -40.05 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 51,700 -22.37 4,524 -31.04 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 66,600 2.62 6,560 -15.14 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 64,900 -19.88 7,730 -24.89 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 81,000 -68.21 10,291 -65.62 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 254,800 56.70 29,936 130.83 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 162,600 231.84 12,969 416.49 n/a n/a n/a
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 49,000 476.47 2,511 689.62 n/a n/a n/a
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 8,500 -46.20 318 -70.31 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 15,800 -29.46 1,071 -13.84 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 22,400 56.64 1,243 40.14 n/a n/a n/a
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 14,300 -40.17 887 -60.53 n/a n/a n/a
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 23,900 279.37 2,247 345.83 n/a n/a n/a
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 6,300 -70.97 504 -80.48 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 21,700 70.87 2,582 95.46 n/a n/a n/a
2015-05-19 2015-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Call 12,700 -48.79 1,321 -45.10 n/a n/a n/a
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 12,700 1,321 n/a n/a n/a
2015-02-13 2014-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 24,800 1,358.82 2,406 1,709.02 n/a n/a n/a
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 1,700 -92.80 133 -91.06 n/a n/a n/a
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 23,600 -86.58 1,487 -87.38 n/a n/a n/a
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS OPT Call 175,900 916.76 11,785 964.59 n/a n/a n/a
2014-02-13 2013-12-31 13F ALNYLAM PHARMACEUTICALS OPT Call 17,300 127.63 1,107 127.78 n/a n/a n/a
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS OPT Call 7,600 58.33 486 226.17 n/a n/a n/a
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS OPT Call 4,800 149 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-13 2025-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 10,000 -82.24 3,976 -74.32 n/a n/a n/a
2026-03-19 2025-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Put 56,300 15,484 n/a n/a n/a
2025-08-14 2025-06-30 13F/A ALNYLAM PHARMACEUTICALS OPT Put 0 0 n/a n/a n/a
2026-02-27 2025-06-30 13F/A ALNYLAM PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-13 2025-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 0 0 n/a n/a n/a
2026-03-17 2025-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 9,000 -79.78 2,430 -76.79 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 9,000 2 n/a n/a n/a
2026-03-19 2024-12-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 44,500 -20.96 10,471 -32.38 n/a n/a n/a
2025-02-13 2024-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 44,500 10 n/a n/a n/a
2024-11-19 2024-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Put 56,300 15 n/a n/a n/a
2026-03-31 2024-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Put 56,300 15,484 n/a n/a n/a
2024-11-15 2024-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 56,300 15 n/a n/a n/a
2026-03-23 2024-06-30 13F/A ALNYLAM PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 0 0 n/a n/a n/a
2026-03-24 2024-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 60,200 0.00 8,997 -21.92 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 60,200 9 n/a n/a n/a
2026-03-25 2023-12-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 60,200 11,523 n/a n/a n/a
2024-02-15 2023-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 60,200 12 n/a n/a n/a
2026-03-30 2023-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-05-04 2023-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 0 0 n/a n/a n/a
2026-03-30 2022-12-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 41,000 9,744 n/a n/a n/a
2023-02-13 2022-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 41,000 10 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 900 153 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 900 153 n/a n/a n/a
2021-05-13 2021-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-11 2020-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 6,900 -71.60 897 -74.65 n/a n/a n/a
2020-11-12 2020-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 24,300 -47.29 3,538 -48.18 n/a n/a n/a
2020-08-12 2020-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 46,100 -37.79 6,828 -15.35 n/a n/a n/a
2020-05-13 2020-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 74,100 -25.83 8,066 -29.89 n/a n/a n/a
2020-02-10 2019-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 99,900 81.64 11,505 160.12 n/a n/a n/a
2019-11-15 2019-09-30 13F/A ALNYLAM PHARMACEUTICALS OPT Put 55,000 66.67 4,423 84.75 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 55,000 4,423 n/a n/a n/a
2019-08-14 2019-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 33,000 155.81 2,394 98.51 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 12,900 -72.08 1,206 -64.19 n/a n/a n/a
2019-02-14 2018-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 46,200 -41.44 3,368 -51.22 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 78,900 46.11 6,905 29.82 n/a n/a n/a
2018-08-14 2018-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 54,000 38.82 5,319 14.81 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 38,900 -77.78 4,633 -79.17 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 175,100 -44.09 22,246 -39.55 n/a n/a n/a
2017-11-14 2017-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 313,200 50.87 36,798 122.24 n/a n/a n/a
2017-08-14 2017-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 207,600 93.12 16,558 200.56 n/a n/a n/a
2017-05-15 2017-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 107,500 34.71 5,509 84.37 n/a n/a n/a
2017-02-14 2016-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 79,800 806.82 2,988 401.34 n/a n/a n/a
2016-11-14 2016-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 8,800 -52.17 596 -41.63 n/a n/a n/a
2016-08-12 2016-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 18,400 -69.23 1,021 -72.46 n/a n/a n/a
2016-05-16 2016-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 59,800 564.44 3,708 338.30 n/a n/a n/a
2016-02-12 2015-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 9,000 -45.78 846 -36.30 n/a n/a n/a
2015-11-13 2015-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 16,600 9.93 1,328 -26.10 n/a n/a n/a
2015-08-14 2015-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 15,100 -49.33 1,797 -42.01 n/a n/a n/a
2015-05-19 2015-03-31 13F/A ALNYLAM PHARMACEUTICALS OPT Put 29,800 1,762.50 3,099 1,899.35 n/a n/a n/a
2015-05-14 2015-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 29,800 3,099 n/a n/a n/a
2015-02-13 2014-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 1,600 -84.76 155 -81.07 n/a n/a n/a
2014-11-14 2014-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 10,500 275.00 819 365.34 n/a n/a n/a
2014-08-14 2014-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 2,800 -98.39 176 -98.49 n/a n/a n/a
2014-05-15 2014-03-31 13F ALNYLAM PHARMACEUTICALS OPT Put 173,500 742.23 11,624 781.94 n/a n/a n/a
2014-02-13 2013-12-31 13F ALNYLAM PHARMACEUTICALS OPT Put 20,600 -76.27 1,318 -76.27 n/a n/a n/a
2013-11-14 2013-09-30 13F ALNYLAM PHARMACEUTICALS OPT Put 86,800 945.78 5,555 2,061.48 n/a n/a n/a
2013-08-14 2013-06-30 13F ALNYLAM PHARMACEUTICALS OPT Put 8,300 257 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.